The prominent enrichment in the PI3K/Akt pathway and other cancer-associated signaling cascades suggests that isalpinin exerts its anticancer effects by modulating these pivotal oncogenic signaling networks in NSCLC. This evidence concerns the gene AKT1 and cancer.